-
1
-
-
0024488322
-
Schizophrenia: A life-shortening illness
-
Allebeck P. 1989. Schizophrenia: A life-shortening illness. Schi-zophr Bull 15:81-89.
-
(1989)
Schi-zophr Bull
, vol.15
, pp. 81-89
-
-
Allebeck, P.1
-
2
-
-
0038207693
-
2 A receptor density but not second messenger inositol triphoshate levels in drug-free schizophrenic patients
-
Arranz B, Rosel P, Sarro S, et al. 2003. Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol triphoshate levels in drug-free schizophrenic patients. Psychiatry Res 118:165-174.
-
(2003)
Psychiatry Res
, vol.118
, pp. 165-174
-
-
Arranz, B.1
Rosel, P.2
Sarro, S.3
-
3
-
-
33750520528
-
Glycerophospholipid molecular species in platelets and brain tissues-are platelets a good model for neurons?
-
Bakken AM, Staeffler A, Jorgensen HA, Holmsen H. 2006. Glycerophospholipid molecular species in platelets and brain tissues-are platelets a good model for neurons? Platelets 17:484-492
-
(2006)
Platelets
, vol.17
, pp. 484-492
-
-
Bakken, A.M.1
Staeffler, A.2
Jorgensen, H.A.3
Holmsen, H.4
-
4
-
-
0033056855
-
Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia
-
Berk M, Plein H, Czismadia T. 1999. Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmaced 14:119-122.
-
(1999)
Int Clin Psychopharmaced
, vol.14
, pp. 119-122
-
-
Berk, M.1
Plein, H.2
Czismadia, T.3
-
5
-
-
0034640382
-
The specificy of platelet glutamate receptor supersensitivity in psychotic disorders
-
Berk M, Plein H, Belsham B. 2000. The specificy of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci 66:2427-2432.
-
(2000)
Life Sci
, vol.66
, pp. 2427-2432
-
-
Berk, M.1
Plein, H.2
Belsham, B.3
-
6
-
-
0018080901
-
Platelet aggregation and chlorpro-mazine therapy
-
Boullin DJ, Know JM, Peters JR, Orr MW, Gelder MG, Grahame-Smith DG. 1978. Platelet aggregation and chlorpro-mazine therapy. Br J Clin Pharmacol 6:538-540.
-
(1978)
Br J Clin Pharmacol
, vol.6
, pp. 538-540
-
-
Boullin, D.J.1
Know, J.M.2
Peters, J.R.3
Orr, M.W.4
Gelder, M.G.5
Grahame-Smith, D.G.6
-
7
-
-
0018423531
-
Inhibition of 5-HAT uptake into neurons and platelets in mice treated chronically with chlorimipramide and femoxetine
-
Buus Lassen J, Lund J, Bechgaard E, Søndergaard I. 1979. Inhibition of 5-HAT uptake into neurons and platelets in mice treated chronically with chlorimipramide and femoxetine. Psychopharmacology 64:149-153.
-
(1979)
Psychopharmacology
, vol.64
, pp. 149-153
-
-
Buus Lassen, J.1
Lund, J.2
Bechgaard, E.3
Søndergaard, I.4
-
8
-
-
0031954102
-
Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects
-
Das I, Khan NS. 1998. Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects. Prostaglandins Leukot Essent Fatty Acids 58:165-168.
-
(1998)
Prostaglandins Leukot Essent Fatty Acids
, vol.58
, pp. 165-168
-
-
Das, I.1
Khan, N.S.2
-
9
-
-
6344276723
-
In vitro effects of risperidone and 9-hydroxyrisperidone on human platelet function, plasma coagulation, and fibrynolysis
-
De Clerck F, Somers Y, Mannaert E, et al. 2004. In vitro effects of risperidone and 9-hydroxyrisperidone on human platelet function, plasma coagulation, and fibrynolysis. Clin Ther 26:1261-1273.
-
(2004)
Clin Ther
, vol.26
, pp. 1261-1273
-
-
De Clerck, F.1
Somers, Y.2
Mannaert, E.3
-
10
-
-
0023522273
-
Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophrenic form or schizophrenic disorders
-
Deminisch L, Gerbaldo H, Gebhart P, Greenspan A, Eerdekens M. 1987. Incorporation of 14C-arachidonic acid into platelet phospholipids of untreated patients with schizophrenic form or schizophrenic disorders. Psychiatry Res 22:275-282.
-
(1987)
Psychiatry Res
, vol.22
, pp. 275-282
-
-
Deminisch, L.1
Gerbaldo, H.2
Gebhart, P.3
Greenspan, A.4
Eerdekens, M.5
-
11
-
-
61649102890
-
Soprostanes as indicators of oxidative stress in schizophrenia
-
Dietrich-Muszalska A, Olas B. 2007. soprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 10: 27-33.
-
(2007)
World J Biol Psychiatry
, vol.10
, pp. 27-33
-
-
Dietrich-Muszalska, A.1
Olas, B.2
-
12
-
-
27644584486
-
Oxidative stress in blood platelets from schizophrenic patients
-
Dietrich-Muszalska A, Olas B, Rabe-Jablonska J. 2005. Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386-391.
-
(2005)
Platelets
, vol.16
, pp. 386-391
-
-
Dietrich-Muszalska, A.1
Olas, B.2
Rabe-Jablonska, J.3
-
13
-
-
61649122462
-
Wplyw dzialania olanzapiny (Zolafren) na peroksydacje lipidow w ludzkich plytkach krwi i osoczu w ukladzie in vitro
-
Dietrich-Muszalska A, Rabe-Jablonska J, Zgirski A. 2004. Wplyw dzialania olanzapiny (Zolafren) na peroksydacje lipidow w ludzkich plytkach krwi i osoczu w ukladzie in vitro. Psychiatr Psychol Klin 4:13-19.
-
(2004)
Psychiatr Psychol Klin
, vol.4
, pp. 13-19
-
-
Dietrich-Muszalska, A.1
Rabe-Jablonska, J.2
Zgirski, A.3
-
14
-
-
3142545995
-
Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
-
Eerdekens M, Hove IV, Remmerie B, et al. 2004. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizoph Res 70:91-100.
-
(2004)
Schizoph Res
, vol.70
, pp. 91-100
-
-
Eerdekens, M.1
Hove, I.V.2
Remmerie, B.3
-
15
-
-
0026450974
-
Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4- phosphate in human platelets
-
Frolich KW, Aarbakke GM, Holmsen H. 1992. Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4-phosphate in human platelets. Biochem Pharmacol 44: 2013-2020.
-
(1992)
Biochem Pharmacol
, vol.44
, pp. 2013-2020
-
-
Frolich, K.W.1
Aarbakke, G.M.2
Holmsen, H.3
-
16
-
-
0034715191
-
Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment
-
DOI 10.1016/S0165-1781(00)00191-8, PII S0165178100001918
-
Govitrapong P, Chgkupit J, Turakitwanakan W, et al. 2004. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment. Psychiatry Res 96:41-50. (Pubitemid 30687408)
-
(2000)
Psychiatry Research
, vol.96
, Issue.1
, pp. 41-50
-
-
Govitrapong, P.1
Chagkutip, J.2
Turakitwanakan, W.3
Srikiatkhachorn, A.4
-
17
-
-
0022253263
-
Different effects of centrally acting drugs on rabbit platelet aggregation: With special reference to selective inhibitiory effects of antipsychotics and antidepressants
-
Ishigooka J, Shizu Y, Wakatabe H, Tanaka K, Miura S. 1985. Different effects of centrally acting drugs on rabbit platelet aggregation: with special reference to selective inhibitiory effects of antipsychotics and antidepressants. Biol Psychiatry 20:866-873.
-
(1985)
Biol Psychiatry
, vol.20
, pp. 866-873
-
-
Ishigooka, J.1
Shizu, Y.2
Wakatabe, H.3
Tanaka, K.4
Miura, S.5
-
19
-
-
0033562632
-
Chlorpromazine and human platelet glycerolipid metabolism: Precursor specificity and significance of drug-platelet interaction time
-
Laasvatn KO, Holmsen H. 1999. Chlorpromazine and human platelet glycerolipid metabolism: precursor specificity and significance of drug-platelet interaction time. Biochem Pharmacol 57:1113-1123.
-
(1999)
Biochem Pharmacol
, vol.57
, pp. 1113-1123
-
-
Laasvatn, K.O.1
Holmsen, H.2
-
20
-
-
26144449142
-
Monoaminergic influence on the visual evoked potentials (VEP)
-
Magos T. 1998. Monoaminergic influence on the visual evoked potentials (VEP). Rec Adv Hum Neurophysiol 1:455-465
-
(1998)
Rec Adv Hum Neurophysiol
, vol.1
, pp. 455-465
-
-
Magos, T.1
-
21
-
-
70450279331
-
Correlation between platelet monoamine oxidase activity and the strength of a visual illusion
-
Magos T. 2001. Correlation between platelet monoamine oxidase activity and the strength of a visual illusion. Vision Res 42: 31-35.
-
(2001)
Vision Res
, vol.42
, pp. 31-35
-
-
Magos, T.1
-
22
-
-
0016368108
-
Monamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues
-
Murphy DL, Donnelly CH. 1974. Monamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues. Adv Biochem Psychopharmacol 12:71-85.
-
(1974)
Adv Biochem Psychopharmacol
, vol.12
, pp. 71-85
-
-
Murphy, D.L.1
Donnelly, C.H.2
-
23
-
-
0036344313
-
Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion
-
Nowak P, Wachowicz B. 2002. Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets 13:293-299.
-
(2002)
Platelets
, vol.13
, pp. 293-299
-
-
Nowak, P.1
Wachowicz, B.2
-
24
-
-
10944249684
-
Left atrial thrombosis associated with antipsychotic drugs
-
Numata S, Kato O, Misawa H, Tokuda H, Kasahara T, Ohmori T. 2005. Left atrial thrombosis associated with antipsychotic drugs. Prog Neuro- Psychopharmacol Biol Psychiatry 29: 153-155.
-
(2005)
Prog Neuro-Psychopharmacol Biol Psychiatry
, vol.29
, pp. 153-155
-
-
Numata, S.1
Kato, O.2
Misawa, H.3
Tokuda, H.4
Kasahara, T.5
Ohmori, T.6
-
25
-
-
0034668175
-
The integrin alpha IIb/beta 3 in human platelet signal transduction
-
Chap H.
-
Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H. 2000. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol 60:1069-1074.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1069-1074
-
-
Payrastre, B.1
Missy, K.2
Trumel, C.3
Bodin, S.4
Plantavid, M.5
-
26
-
-
0035001754
-
The platelet as a peripheral marker in psychiatric illness
-
Plein H, Berk M. 2001. The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol Clin Exp 16: 229-236.
-
(2001)
Hum Psychopharmacol Clin Exp
, vol.16
, pp. 229-236
-
-
Plein, H.1
Berk, M.2
-
27
-
-
33846640656
-
Blunted serotonergic responsivity in neurolrptic-näive patients at first-episode of schizophrenia
-
Reddy R, Keshavan M, Yao JK. 2007. Blunted serotonergic responsivity in neurolrptic-näive patients at first-episode of schizophrenia. Schizophr Res 90:8105.
-
(2007)
Schizophr Res
, vol.90
, pp. 8105
-
-
Reddy, R.1
Keshavan, M.2
Yao, J.K.3
-
28
-
-
0034669992
-
Molecular mechanisms of platelet exocytosis: Insights into the secrete life of thrombocytes
-
Reed GL, Fitzgerald ML, Polgar J. 2000. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood 96:3334-3342.
-
(2000)
Blood
, vol.96
, pp. 3334-3342
-
-
Reed, G.L.1
Fitzgerald, M.L.2
Polgar, J.3
-
29
-
-
0034902812
-
The platelet release reaction: Granules, constituents, secretion and functions
-
Rendu F, Brohard-Bohn B. 2001. The platelet release reaction: granules, constituents, secretion and functions. Platelets 12:261-273.
-
(2001)
Platelets
, vol.12
, pp. 261-273
-
-
Rendu, F.1
Brohard-Bohn, B.2
-
30
-
-
0035086450
-
Dopamine receptors in human platelets
-
Ricci A, Bronzetti E, Mannino F, Mignini F, Morosetti C, Tayebati SK, et al. 2001. Dopamine receptors in human platelets. Naunyn-Schmiedeberg's Arch Pharmacol 363: 376-382.
-
(2001)
Naunyn-Schmiedeberg's Arch Pharmacol
, vol.363
, pp. 376-382
-
-
Ricci, A.1
Bronzetti, E.2
Mannino, F.3
Mignini, F.4
Morosetti, C.5
Tayebati, S.K.6
-
32
-
-
0032421570
-
The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
-
Sheehan DV, Lecrubier Y, Sheehan KH, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22-33.
-
(1998)
J Clin Psychiatry
, vol.59
, pp. 22-33
-
-
Sheehan, D.V.1
Lecrubier, Y.2
Sheehan, K.H.3
-
33
-
-
0034082029
-
Abnormal levels of camp-dependent protein kinase regulatory subunits in platelets from schizophrenic patients
-
Tardito D, Tura GB, Bocchio L. 2000. Abnormal levels of camp-dependent protein kinase regulatory subunits in platelets from schizophrenic patients. Neuropsychopharmacology 23: 216-219.
-
(2000)
Neuropsychopharmacology
, vol.23
, pp. 216-219
-
-
Tardito, D.1
Tura, G.B.2
Bocchio, L.3
-
35
-
-
4344631943
-
Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence?
-
Von Kanel R. 2004. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand 110:163-177.
-
(2004)
Acta Psychiatr Scand
, vol.110
, pp. 163-177
-
-
Von Kanel, R.1
-
36
-
-
0036839123
-
IIIa in drug-näive, first-episode schizophrenic patients
-
Walsh MT, Ryan M, Hillmann A, et al. 2002. Elevated expression of integrin aIIbbIIIa in drug-näive, first-episode schizophrenic patients. Biol Psychiatry 52:874-879.
-
(2002)
Biol Psychiatry
, vol.52
, pp. 874-879
-
-
Walsh, M.T.1
Ryan, M.2
Hillmann, A.3
-
37
-
-
0034730185
-
Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs
-
Yang J, Wu J, Kowalska MA, et al. 2000. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 97:9984-9999.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 9984-9999
-
-
Yang, J.1
Wu, J.2
Kowalska, M.A.3
-
39
-
-
0029658390
-
Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia
-
Yao JK, van Kammen DP. 1996. Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:21-26.
-
(1996)
Prostaglandins Leukot Essent Fatty Acids
, vol.55
, pp. 21-26
-
-
Yao, J.K.1
Van Kammen, D.P.2
-
41
-
-
0034619072
-
Antipsychotic drug and risk of first-time idiopathic venous thromboembolism: A case-control study
-
Zornberg GL, Jick H. 2000. Antipsychotic drug and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 356:1219-1223.
-
(2000)
Lancet
, vol.356
, pp. 1219-1223
-
-
Zornberg, G.L.1
Jick, H.2
|